Remove 2026 Remove Appointment Remove Clinic Remove Management
article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Some members of the Specialty Board were interested in the LKA experience, participant survey results—particularly responses about fairness—and how LKA performance data might reflect on clinical outcomes. ABIM’s website features expansive sections on research related to assessment and clinical outcomes.

article thumbnail

“TAP Dancing” Towards Faster Device Commercialization: CDRH’s Total Product Life Cycle Advisory (“TAP”) Program

FDA Law Blog

Also, it is unclear which office within CDRH appoints the TAP Advisor, e.g., center-level, OPEQ-level, or division-level. Review teams already appoint a lead reviewer to each submission and sometimes assign a project manager to an extensive project. up to 125 total products enrolled through FY 2025).

article thumbnail

GeriPal Takeover! Nancy Lundeberg and Annie Medina-Walpole

GeriPal

I will always, as always, say, you know, you’re welcome to do this in 2026. Ken 12:14 I’ll remind you, Nancy, that this is an honor for companies that manage to make lots of money despite having a product that’s worthless or doesn’t. It always has clinical relevance to practice today. Of course.

IT 64